Key terms
About RVTY
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RVTY news
Apr 02
6:03am ET
Revvity announces preliminary injunction compelling CSG to comply with contract
Mar 20
5:05pm ET
Revvity files complaint against Cloud Software Group, affirms FY24 guidance
Feb 02
8:10am ET
Analysts Conflicted on These Healthcare Names: Exelixis (EXEL), Revvity (RVTY) and Becton Dickinson (BDX)
Feb 02
6:47am ET
Revvity price target raised to $123 from $121 at Baird
Feb 02
6:03am ET
Revvity price target raised to $126 from $110 at KeyBanc
Feb 01
8:08pm ET
Revvity price target raised to $116 from $105 at Barclays
Feb 01
8:06pm ET
Revvity: A Cautious Hold Amidst Conservative Guidance and Operational Challenges
Feb 01
5:05pm ET
Buy Rating Affirmed: Revvity’s Promising Turnaround and Prudent 2024 Outlook
Feb 01
8:25am ET
Revvity: Hold Rating Affirmed Amidst Mixed Financial Performance and Cautious Outlook
Feb 01
6:12am ET
Revvity sees 2024 EPS $4.55-$4.75, consensus $4.60
Feb 01
6:11am ET
Revvity reports Q4 adjusted EPS $1.25, consensus $1.16
Jan 27
4:05am ET
Revvity Board Changes: Directors Depart and New Appointments
Jan 24
7:20am ET
Revvity price target raised to $105 from $92 at Barclays
Jan 09
9:55am ET
Early notable gainers among liquid option names on January 9th
Jan 04
7:24am ET
Revvity upgraded to Outperform from In Line at Evercore ISI
No recent press releases are available for RVTY
RVTY Financials
Key terms
Ad Feedback
RVTY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RVTY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range